These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 16118084)

  • 1. Impressive regression of primary liver cancer after treatment with sirolimus.
    Rizell M; Cahlin C; Friman S; Hafström L; Lönn L; Olausson M; Lindner P
    Acta Oncol; 2005; 44(5):496. PubMed ID: 16118084
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatocellular cancer, transplantation, and sirolimus.
    Wall WJ
    Liver Transpl; 2004 Oct; 10(10):1312-4. PubMed ID: 15376337
    [No Abstract]   [Full Text] [Related]  

  • 3. Pilot study: rapamycin in advanced hepatocellular carcinoma.
    Schöniger-Hekele M; Müller C
    Aliment Pharmacol Ther; 2010 Sep; 32(6):763-8. PubMed ID: 20629977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant conversion to sirolimus in liver transplant patients with recurrent hepatocellular carcinoma - preliminary results.
    Kornberg A; Küpper B; Tannapfel A; Thrum K; Wilberg J; Bärthel E; Settmacher U
    Transpl Int; 2008 Jan; 21(1):96-9. PubMed ID: 17903182
    [No Abstract]   [Full Text] [Related]  

  • 5. Activation of the mammalian target of rapamycin signaling pathway in hepatocellular carcinoma.
    Subbiah IM; Brown RE; Fallon MB
    Hepatology; 2010 Oct; 52(4):1524. PubMed ID: 20680964
    [No Abstract]   [Full Text] [Related]  

  • 6. Spontaneous complete necrosis of hepatocellular carcinoma: a case report.
    Li AJ; Wu MC; Cong WM; Shen F; Yi B
    Hepatobiliary Pancreat Dis Int; 2003 Feb; 2(1):152-4. PubMed ID: 14607670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spontaneous regression of hepatocellular carcinoma.
    Sibartie V; Moriarty J; Crowe J
    Am J Gastroenterol; 2008 Apr; 103(4):1050-1. PubMed ID: 18397439
    [No Abstract]   [Full Text] [Related]  

  • 8. [Basic and clinical study of interferon a in hepatocellular carcinoma].
    Sun HC; Wang L; Wu WZ
    Zhonghua Wai Ke Za Zhi; 2008 Nov; 46(21):1606-8. PubMed ID: 19094750
    [No Abstract]   [Full Text] [Related]  

  • 9. [Autopsy case of liver cancer undetected until the terminal stage].
    Hattori M; Katsuta K; Hozumi M
    Iryo; 1970 Mar; 24(3):249-55. PubMed ID: 4316183
    [No Abstract]   [Full Text] [Related]  

  • 10. Sirolimus-based immunosuppression therapy in liver transplantation for patients with hepatocellular carcinoma exceeding the Milan criteria.
    Zhou J; Wang Z; Wu ZQ; Qiu SJ; Yu Y; Huang XW; Tang ZY; Fan J
    Transplant Proc; 2008 Dec; 40(10):3548-53. PubMed ID: 19100435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. De novo sirolimus-based immunosuppression after liver transplantation for hepatocellular carcinoma: long-term outcomes and side effects.
    Toso C; Meeberg GA; Bigam DL; Oberholzer J; Shapiro AM; Gutfreund K; Ma MM; Mason AL; Wong WW; Bain VG; Kneteman NM
    Transplantation; 2007 May; 83(9):1162-8. PubMed ID: 17496530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of long-term outcome following liver transplantation for hepatocellular carcinoma: a single-center experience.
    Zimmerman MA; Trotter JF; Wachs M; Bak T; Campsen J; Wright F; Steinberg T; Bennett W; Kam I
    Transpl Int; 2007 Sep; 20(9):747-53. PubMed ID: 17565579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic treatment in advanced/metastatic hepatocellular carcinoma in the era of targeted therapy.
    Han KH; Park JY
    J Gastroenterol Hepatol; 2010 Jun; 25(6):1023-5. PubMed ID: 20594213
    [No Abstract]   [Full Text] [Related]  

  • 14. [Spontaneous regression of hepatocellular carcinoma].
    Ledesma S; Boada L; Titó L; Armengol S; Torres M
    Gastroenterol Hepatol; 1998 Nov; 21(9):469-70. PubMed ID: 9882942
    [No Abstract]   [Full Text] [Related]  

  • 15. Cirrhotomimetic type hepatocellular carcinoma diagnosed after liver transplantation--eighteen months of follow-up: a case report.
    Han YS; Choi DL; Park JB
    Transplant Proc; 2008 Oct; 40(8):2835-6. PubMed ID: 18929876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polyprenoic acid in hepatocellular carcinoma.
    Yang CH; Cheng AL
    N Engl J Med; 1996 Nov; 335(19):1460-61; author reply 1461-2. PubMed ID: 8927081
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of a chemotherapeutic regimen for primary liver cancer in children.
    Senzer NN; Terrell W; Pratt CB
    Cancer Treat Rep; 1978 Sep; 62(9):1403-4. PubMed ID: 210945
    [No Abstract]   [Full Text] [Related]  

  • 18. Successful treatment with low-dose oral chemotherapy in a patient with metastatic hepatocellular carcinoma.
    Di Meglio G; Fazio N; Nolè F; Della Vigna P; Lorizzo K; Goldhirsch A; Farris A
    Acta Oncol; 2007; 46(8):1205-6. PubMed ID: 17978934
    [No Abstract]   [Full Text] [Related]  

  • 19. Polyprenoic acid in hepatocellular carcinoma.
    Decensi A; Costa A
    N Engl J Med; 1996 Nov; 335(19):1461; author reply 1461-2. PubMed ID: 8927082
    [No Abstract]   [Full Text] [Related]  

  • 20. Spontaneous regression of hepatocellular carcinoma with complete necrosis: case report.
    Ohta H; Sakamoto Y; Ojima H; Yamada Y; Hibi T; Takahashi Y; Sano T; Shimada K; Kosuge T
    Abdom Imaging; 2005; 30(6):734-7. PubMed ID: 16252150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.